Liraglutide TFA

42 Cited Publications
Customer Review

Based on 42 publication(s) in Google Scholar

Liraglutide (TFA) is an agonist of glucagon-like peptide 1 receptor (GLP-1). Liraglutide (TFA) can activate GLP-1, leading to the release of insulin in the presence of increased glucose concentration. Liraglutide (TFA) also reduces glucagon secretion in a glucose-dependent manner. Liraglutide (TFA) can be studied in research on type 2 diabetes.

For research use only. We do not sell to patients.

  • Purity: 99.56%
  • Formula: C172H265N43O51.xC2HF3O2
  • Molecular Weight:3751.20 (free base)
  • Storage:

    Sealed storage, away from moisture.

    Powder   -80°C, 2 years , -20°C, 1 year

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Liraglutide TFA

More
Customer Validation & Images
IFOthersRT-PCRWB
  • IF
  • Others
  • RT-PCR
  • WB
  • WB
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00